Current characteristics of dialysis therapy in Korea: 2016 registry data focusing on diabetic patients.
10.23876/j.krcp.2018.37.1.20
- Author:
Dong Chan JIN
1
;
Sung Ro YUN
;
Seoung Woo LEE
;
Sang Woong HAN
;
Won KIM
;
Jongha PARK
;
Yong Kyun KIM
Author Information
1. Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea. jindongc@catholic.ac.kr
- Publication Type:Original Article
- Keywords:
Diabetes mellitus;
Dialysis adequacy;
Korea;
Renal dialysis;
Renal replacement therapy
- MeSH:
Arteriovenous Fistula;
Blood Pressure;
Creatinine;
Diabetes Mellitus;
Diabetic Nephropathies;
Dialysis*;
Glomerulonephritis;
Humans;
Kidney Failure, Chronic;
Korea*;
Nephrology;
Renal Dialysis;
Renal Replacement Therapy;
Survival Rate
- From:Kidney Research and Clinical Practice
2018;37(1):20-29
- CountryRepublic of Korea
- Language:English
-
Abstract:
Diabetic nephropathy is the most frequent cause of end-stage renal disease worldwide. Dialysis patients with diabetes mellitus (DM) have more complications and shorter survival duration than non-DM dialysis patients, requiring more clinical attention and difficult management. The registry committee of the Korean Society of Nephrology has collected data about dialysis therapy in Korea through an on-line registry program and analyzed the characteristics of patients. A survey of dialysis patients in 2016 showed that 50.2% of new dialysis patients had DM nephropathy as the cause of end-stage renal disease. The proportion of patients receiving hemodialysis (HD) for more than 5 years was 38% in DM patients and 51% in non-DM patients. The mean pulse pressure in DM HD patients was 71.5 mmHg, compared with 62.6 mmHg in non-DM patients. The proportion of DM patients with native vessel arteriovenous fistula as vascular access for HD was lower than that of non-DM patients (73% vs. 78%). Mean serum creatinine of DM and non-DM dialysis patients was 8.4 mg/dL and 9.5 mg/dL respectively. As vascular access of the DM HD patients was poor, the dialysis adequacy of DM patients was slightly lower than that of non-DM patients. The 5-year survival rate for DM HD patients was 53.9%, which was much lower than that of chronic glomerulonephritis patients (78.2%). The proportion of patients with a full-time job was 17% for DM patients and 28% for non-DM patients.
